AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1

In the United States, one-third of population is affected by obesity and almost 29 million people are suffering from type 2 diabetes. Obese people have elevated serum levels of insulin, insulin-like growth factor 1 (IGF1), and interleukin-17 (IL-17). Insulin and IGF1 are known to enhance IL-17-induc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Chen, Chong, Zhang, Qiuyang, Liu, Sen, Lambrechts, Mark, Qu, Yine, You, Zongbing
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2014
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249256/
https://ncbi.nlm.nih.gov/pubmed/25520943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00343
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы